/
Where does Testosterone  come from ? Where does Testosterone  come from ?

Where does Testosterone come from ? - PowerPoint Presentation

Honeybunches
Honeybunches . @Honeybunches
Follow
350 views
Uploaded On 2022-07-28

Where does Testosterone come from ? - PPT Presentation

Androgens ovary and adrenals 5050 Deficiency common after BSO Testosterone by 50 in post menopausal Premature Ovarian Insufficiency 23 have low sex drive After menopause imbalance of hormones very low E relative high T therefore due to imbalance women can have slig ID: 930280

sex testosterone months levels testosterone sex levels months fai test drive bso nmol women shbg free label female hrt

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Where does Testosterone come from ?" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Where does Testosterone come from ?

Androgens : ovary and adrenals ( 50:50)

Deficiency common

after BSO (Testosterone ↓ by 50%)

in post menopausal

Premature Ovarian Insufficiency (*2/3 have low sex drive)

After menopause : imbalance of hormones , very low E , relative high T, therefore due to imbalance women can have slight

hirsuitism

Slide2

Testosterone Assays

Assays not sensitive : Immunoassay and Mass spectrophotometry

Blood levels not equal to tissue levels, assays imprecise at low levels and cross react with with NET

Correlation of levels with Symptoms is poor, offers no diagnostic valueBioavailable testosterone : free Testosterone , not bound to SHBG , and intracranial Testosterone in CNS may play a role too Free test , Free Androgen Index (FAI) is importantFAI= Total Testosterone x100 SHBG Interpretation of assaysBaseline tests – Serum Test < 1.7 nmol/L, ( post menopause) and in POI <7%( <40urs )Androfeme 1 cream 0.5 ml daily . At 3 months FAI ↑ to 3, Test = 1 nmol/L Davis, Baber , Panay et al . Climacteric ,Maturitas. J Sex Med , JCEM 2/9/19

Slide3

Cases with Reduced sex Drive

Josie, Age 55 , works in Public Health

TAH with BSO at 50 for heavy periods

Happily married x 30 yrs Has low sex drive –is affecting her relationship for few years No VVA, hot flushes have settled Not depressed , no stressful contributing factors, no medications, sex once in 3 months TFTS – nad , Serum Test =0.2 nmol/l , FAI ( cannot be calculated) , SHBG =35 Rosie, Age 55 , NHS Manager Periods stopped at 53

On HRT x 2 years , hot flushes better

Happily married x 30

yrs

Main problem is low sex drive Affecting her relationship Not depressed , no stressful contributing factors, no medications, sex once in 3 months TFTs – nad , Serum Test = 0.5 nmol/L , FAI cannot be calculated , SHBG = 56

Will you consider Testosterone ?

Slide4

Testosterone: Global Consensus Position statement on Use of Testosterone therapy for women

Where an appropriate approved female testosterone preparation is not available, off label, prescribing of an approved male formulation is reasonable, provided hormone concentrations are maintained in the physiologic female range.

No recommendations for use in premenopausal women , lack of data

Evidence based Indications recommended by IMS ( Task Force) HSDD – Hypoactive sexual desire disorder FAD – Female arousal disorder FOD – Female Orgasmic disorder Dose recommended in post menopause with or without HRT equal to premenopausal concentration - Post menopausal- BSO ( Surgical menopause) TestosteronePremature Ovarian Insufficiency (POI) Insufficient evidence to support use for cognitive function, mood , bone mineral density, well being, sarcopenia , energy levels , headaches Safety : Only data on Short term transdermal T therapy : no impact on breast cancer, lipid profile, CVS, bone, AND long term insufficient data

www.imsociety.org

,

Davis et al. Global Consensus Position Statement on the use of Testosterone Therapy for Women.

Maturitas. 2019;128:89-93.

Slide5

Role of Testosterone

Testosterone : 100-400mcg/day (

usedto

be available in patch form discontinued) EMAS approved use of Testosterone patches , Testosterone Implant for women with BSO who are on E2 replacement only NICE Guidance : Trial of Systemic HRT before Testosterone RX Baseline tests – Serum Test <1.7 nmol/L, FAI low usually <1Preparations available (5 mg/day)Unlicensed , off label use Testogel ™1 sachet x 10 days ( 0.5 ml=5 mg /day) off label Tostran gel ™(2%) 1 measure on alternate days (off label ) Androfeme 1 cream™ – 0.5 ml daily ( unlicensed use-imported) Testosterone Implant 100 mg yearly ( unlicensed, in pts with TAH with BSO)Tibolone does help sex drive , less E side effects, breast less dense, less breast cancer risk cf combined HRT, higher risk of stroke over 60s

Repeat Testosterone levels

at ideally 3-6 weeks and every 6 months

but BMS guidance: repeat at 3 months , followed by once a year

( FAI < 5) If no response in 3-6 months , discontinue Rx. Androfeme 1 cream ™by Lawley Pharma www.independentpharmacy.co.ukAn Endocrine Society Cl Practice Guideline . Wierman et al. JCEM2014, Climacteric, Maturitus

2/9/19

Slide6

Adverse effects of Testosterone

Occasional : increased hair growth at site

Uncommon :

hirsuitism, acne , alopecia Rare : deepening of voice , enlarged clitoris Contra-indication 1. Breast cancer , other E-hormone dependent cancers 2. Active liver disease 3. High baseline and Free Androgen Index